A. Rossi et al., CAROTID-ARTERY LESIONS IN PATIENTS WITH NONDIABETIC CHRONIC-RENAL-FAILURE, American journal of kidney diseases, 27(1), 1996, pp. 58-66
Atherosclerotic complications are the leading cause of death in chroni
c renal failure (CRF) patients. Therefore, we wished to investigate th
e prevalence of carotid artery lesions (CALs) in these subjects. Two g
roups were evaluated by high-resolution echo Doppler: group 1 included
103 patients (68 males and 35 females) affected by nonnephrotic CRF a
nd group 2 included 100 control subjects (60 males and 40 females). Th
e prevalence of hypertension was 84% in both groups. The exclusion cri
teria included diabetes mellitus and symptoms of cerebrovascular disea
se. In the two groups we evaluated clinical history, physical examinat
ion, total cholesterol, triglycerides, fibrinogen, blood cell counts,
blood urea nitrogen, creatinine, 24-hour proteinuria, and urine analys
is. In group 1 patients the following lipid profile parameters were al
so evaluated: low-density lipoprotein cholesterol, high-density lipopr
otein cholesterol, lipoprotein(a), ApoAl, ApoAll, and ApoB. Group 1 ha
d higher triglycerides and fibrinogen than group 2. A lower body mass
index was found in group 1 than in group 2. The prevalence of CALs was
significantly higher in the CRF patients than in the control subjects
(62% v 47%; P = 0.04). The difference between the two groups was more
striking among normotensive patients (62% v 19%; P = 0.03). All CRF p
atients affected by peripheral arterial disease and 86% of those havin
g coronary artery disease had associated CALs. In CRF patients the sev
erity of CALs was positively correlated to age, white blood cell count
, triglycerides, and fibrinogen. Nondiabetic CRF patients have a highe
r prevalence of carotid artery lesions than control subjects. Several
factors besides hypertension, including lipids, blood coagulation, and
leukocytes, could contribute to the accelerated atherosclerosis of CR
F patients. (C) 1996 by the National Kidney Foundation, Inc.